BELLEVUE LIFE SCIENCES ACQUISITION CORP. Profile Avatar - Palmy Investing

BELLEVUE LIFE SCIENCES ACQUISITION CORP.

None

None, None [HQ]
Financials

Analysts

Earnings
Reported
Past Estimate Consensus
Future Estimate Consensus
BELLEVUE LIFE SCIENCES ACQUISITION CORP. can't present any analysts estimates at the moment detail analysis.
Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Overall Consensus
Grading Consensus
Click to each, to see the grade
BELLEVUE LIFE SCIENCES ACQUISITION CORP. can't present the grade consensus distribution right now.
Price Target Consensus
Price Then
$n/a
Price Target
$n/a
Price Now
$11.89
End of BLACU's Analysis
CIK: - CUSIP: - LEI: - UEI: -
Secondary Listings
BLACU has no secondary listings inside our databases.